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The national availability of medicines 
is monitored by the Pharmaceutical Unit. 
The Malta Medicines List (MML) is kept 
updated with all the medicines authorised 
to be placed on the market. The list is a 
national formulary which includes those 
medicines authorised by the local Medicines 
Authority as well as those authorised by 
the European Medicines Agency which 
are imported and placed on the Maltese 
market. Such monitoring together with the 
implementation of the ‘Guidelines for the 
supply of medicinal products for human use 
through processes which are not covered by 
the Medicines Act, 200 and its subsidiary 
legislation’, ensure that the public’s 
pharmaceutical needs are met.
The MML provides information useful 
for both the health care professional and 
the patient, with the aim of improving 
the rational use of medicines. According 
to the World Health Organisation (WHO), 
rational medicines use requires that patients 
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The unit implements local legislation and fulfils international 
obligations with respect to narcotic drugs, psychotropic substances 
and precursor chemicals. It is also responsible for the development 
and setting of policies in various pharmaceutical areas, as well as for 
the implementation and monitoring of the set policies.
receive medications appropriate to their 
clinical needs, in doses that meet their 
individual requirements, for an adequate 
period of time, and at the lowest possible 
cost to them and their community. The 
Pharmaceutical Unit has the mission 
of empowering health professionals 
and consumers to use medicine in a 
therapeutically sound and cost-effective 
manner. 
Following European Union accession, 
Malta transposed the EU legislation into 
the Medicines Act 200 and its subsidiary 
legislation, so that the medicinal products 
available are all up to the European Union 
standards of quality i.e. as demanded by 
the Directive 2001/8/EC of the European 
Parliament and of the Council of 6 November 
2001 on the Community code relating to 
medicinal products for human use. 
By ensuring the quality, safety and 
efficacy of medicinal products, patient 
safety is enhanced. The Pharmaceutical 
Unit supports such regulations and deals 
with medicine policies which safeguard 
the patients’ rights and wellbeing, and 
which boost the healthcare professionals’ 
confidence in the medicinal products 
available, from their manufacture to 
administration and use by the patient.
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